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The storage conditions of the donor kidney may influence
the deleterious consequences of ischemia/reperfusion (IR),
which remains a major source of complications in clinical
practice. Delayed graft function (DGF), seen in 20% to 50% of
transplanted cadaver kidneys, is a major risk factor affecting
early and long-term graft survival, patient management, and
costs of transplantation. Cold preservation plays a key role in
this process and is based on hypothermia and high
potassium solutions. In this review, the authors focused on
the major molecular mechanisms of cold storage (CS) injury
at the cellular level, which have been recently evidenced with
modern biochemical and cell biologic methods. These newly
uncovered aspects of cold preservation injury are often not
fully addressed by preservation solutions in current clinical
practice. The role of new molecules such as polyethylene
glycol (PEG) is presented and their properties are analyzed in
the organ preservation context. PEG improves organ function
recovery and reduces inflammation and fibrosis development
in several models. Because organs shortage is also a real
public health problem, organs from non-heart beating
donors or marginal donors are now used to expand pool of
organs. As a consequence, the development of better organ
preservation methods remains a major target and deserves
scientific consideration.
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Till date, the procedure of organ transplantation requires the
grafted organ to go through phases of cold preservation and
warm reperfusion. The resulting ischemia–reperfusion injury
(IRI) typically causes early nonfunction or delayed graft
function, which plays an important role in the development
of chronic graft failure and late graft loss (Figure 1).1 In
addition, the shortage of donors has led many transplant
centers to consider accepting older donors with co-morbi-
dities, more prone to delayed graft function. Consequently,
the incidence of delayed graft function remains high and the
importance of the preservation procedure is now well
established.
BASIC PRINCIPLES OF ORGAN PRESERVATION
The basic principles of organ preservation rely on two empi-
rical dogmas: (i) low-temperature preservation and (ii) high-
potassium solutions.2 Low temperature is used to decrease
the metabolic rate of a nonperfused organ; however, it can
also induce some deleterious effects, and even if it remains
the most commonly used strategy, there is still room for the
development of preservation procedures at higher tempera-
ture, room temperature, or even normothermia, especially
when perfusion is associated with preservation.
The high-Kþ dogma relies on the hypothesis that as the
function of ionic pumps is impaired during preservation, the
intracellular ionic content can be maintained using an
extracellular preservation solution with a similar ionic
content. This concept is offset by several observations:1,3 (i)
high potassium induces cellular depolarization and accel-
erates the decrease in the cellular ATP content; (ii) voltage-
dependent channels, such as calcium channels, are activated;
and (iii) the consecutive calcium influx depends on the
potassium concentration of the solution. Most importantly,
potassium concentration above 15 mmol/L is a potent
stimulus of vasoconstriction that impairs organ perfusion
during washout and reperfusion.
Despite the evolution of preservation techniques—at
various temperatures and with or without continuous
pulsatile perfusion—major factors determining organ viabi-
lity before transplantation should be taken into account.
One of the most important is tissue edema. Many events
contribute to cellular and mitochondrial swelling during
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preservation. The initial mechanism was believed to be the
inhibition of Naþ /Kþ ATPase followed by intracellular
accumulation of sodium, chloride influx, and cell swelling.
This mechanism was the corner stone to validate the use of
‘intracellular ion content’ preservation solutions associated
with high concentrations of osmotically active substances.
Suppression of oxidative phosphorylation, ATP depletion,
and increase in the cytosolic calcium concentration were
widely regarded as consequences of the inhibition of Ca2þ
ATPase and the reverse mode of function of the Naþ /Ca2þ
antiporter. Mitochondrial calcium overload follows this
increase in cytosolic calcium, and is associated with the
opening of the permeability transition pore and mitochon-
drial swelling.1,2 This mitochondrial swelling was correlated
with proapoptotic events.
The second factor, which impacts organ viability, is
oxidative stress.1,3 Recent reports have shown that the
primary mechanism of hypothermic injury was related to
free iron release of microsomal origin.1 Mitochondria are a
major cellular source of free radicals and their role was
underlined by the increased expression of MnSOD messen-
ger.1,3 These data emphasize the role of mitochondria in
hypothermic and cold-induced injury, which are mediated by
reactive oxygen species (ROS), with the cellular labile iron
pool playing a decisive role in this injury. The main oxidative
stress occurs at the time of reperfusion, when oxygenated
blood flow is restored. The reintroduction of oxygen
molecules is characterized by the univalent reduction of
dioxygen molecules, leading to ROS production and direct
injury to cellular structures as well as activation of different
cellular signaling pathways.4 Both ROS and calcium can
strongly contribute to the opening of the mitochondrial
permeability transition pore.1,3 Strategies to alleviate ROS-
related damage should be aimed at limiting their production
during cold preservation and at the time of reoxygenation
and rewarming rather than the more difficult approach of
neutralizing the already produced ROS.
A third factor is the preservation of cell membrane
integrity, and, particularly, that of endothelial cells, which are
in direct contact with the cold storage solution during
preservation. In addition, it is important to maintain the
integrity of the glycocalyx (Gcx),5 which provides both
protection against swelling and limits the visibility of
allogenic molecules at the surface of the membrane of the
endothelial cell.
NEW PRESERVATION SOLUTIONS: THE ERA OF NEW
POLYMERS AND THE PURSUIT OF PERFECTION
Among the key components of preservation solutions,
colloids are essential in preventing or minimizing interstitial
edema. Hydroxyethyl starch was chosen for the preparation
of the UW solution, but was found to cause increased
red blood cell aggregation. Furthermore, glutathione added
in UW solution for its antioxidant property was shown to
be oxidized with time.1 Since then, other colloids have
emerged, notably polyethylene glycol (PEG), which have
physical and chemical properties of particular interest in
organ preservation.6
Immunocamouflage
An alternative to the transplantation tolerance paradigm is
the ‘immunocamouflage’ of foreign cells, tissues, and
organs.7 Immunocamouflage relies on the modification of
the cell membrane surface with non-immunogenic mole-
cules, such as PEG molecules, creating a barrier that prevents
the recognition of allogenic sites on the cell membrane by
circulating cells and antibodies of the recipient. In contrast to
other immunomodulatory approaches, immunocamouflage
presents a more versatile effect combining interferences with
binding, allorecognition, and presentation pathways.7 To
understand this mechanism, we must consider the so-called
immunological synapse.8
The immunological synapse
T cells are normally activated through direct contact with
an antigen-presenting cell. The immunological synapse
organizes and segregates functional antigen (LFA-1) and
T-cell receptor (TCR) molecules on host lymphocyte
membrane from adhesion molecules (ICAM-1) and MHC
(major histocompatibility complex) molecules on donor
antigen-presenting cells. The interaction between T cells and
antigen-presenting cells requires membranes to be in a close
proximity: 15 nm at the MHC and TCR level and 45 nm
between adhesion molecules.9 (Figure 2, left panel)
A sustained TCR engagement can be impeded by the small
size of the TCR and MHC molecules and, furthermore,
engagement of TCR with antigens requires a rearrangement
of proteins at the membrane surface, emphasizing the
importance of cell membrane fluidity. All these events
can be dramatically disturbed if polymers interact at the
membrane surface of donor cells, increasing the distance
between receptors and ligands, and reducing the lateral
mobility of molecules. This is the case with PEG molecules of
molecular weight (MW) greater than or equal to 20 kDa, at a
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Figure 1 | Several pathophysiological processes involved in
organ preservation and reperfusion injury. Preserved and
reperfused organ injury is triggered by hypoxia/reoxygenation
and by hypothermia/rewarming.
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the molecule at the membrane surface produces an exclusion
space of roughly 15–20 nm in length, which is approximately
the size of the immunological synapse.
Nevertheless, PEG molecules adsorbed at the cell mem-
brane surface are eventually cleared, as after kidney
transplantation, the urinary excretion of PEG lasts roughly
1 week. However, the long-term effect of a transitory
camouflage of cell surface antigens is not fully explained.
According to the Danger Signal theory,10 IRI strongly triggers
the recipient immune system (both innate and adaptive).
This acute, short-lived situation is known to have deleterious
long-term effects. Therefore, it is likely that a transient
reduction of antigen presentation (and thus allorecognition)
during the acute phase of the inflammatory process (danger
signal) would minimize the response of the recipient immune
system.
Possible polymers candidates
Numerous hydrophilic polymers can spontaneously bind
to cells and tissues, such as dextran (W23), Tween, Brij,
polymers with phospholipid polar groups, hyaluronic acid,
alginic acid, heparin, albumin, and PEG. However, PEG
seems to be the more effective at sterically stabilizing
underlying surfaces (Figure 2, right panel).
Polyethylene glycols
The outstanding protection provided by this polymer has
been attributed to its molecular properties, such as its
low interfacial energy, three-dimensional conformation,
hydrophilicity, and high flexibility. PEG 20,000 is a polymer
of ethylene oxide with a hydroxyl terminal (Figure 3). The
longer chains are also referred to as polyethylene oxide,
HO-(CH2CH2O)nCH2-CH2-OH. The length of the chain
determines the MW of the molecule, that is, PEG 20,000 has
a MW of 20 kDa.
The possible therapeutic use of PEG is underlined by its
chemical properties: PEG is a neutral, water soluble, nontoxic
polymer. Its unusual water solubility is the result of a specific
water-structuring effect along the backbone of PEG mole-
cules. Thus, with a molecule of PEG 20,000, 8000–10,000
water molecules have reduced mobility and are highly
‘structured’. This leads to the creation of a large ‘exclusion
volume’, which prevents the approach of the other molecules.
Consequently, PEG is not immunogenic, and behaves as a
‘stealth molecule’ or a voluminous water cluster. The
adsorption or exclusion of PEG molecules at the membrane
surface depends on its MW: high MW (410,000 Da) PEG
is adsorbed to the membrane surface and stabilizes it,
whereas lower MW PEGs will be repelled from the membrane
surface, and the depletion–attraction mechanism will lead to
membrane fusion (PEG 8000 or 10,000). There is a critical
chain length above which a sufficient number of segments
form physical bonds with the surface, and large chains are
preferentially adsorbed.
PEG molecules adsorbed to the cell membrane surface can
exert a long-range effect impeding the interaction between
surface molecules roughly up to 50 nm for a MW of 20 kDa.
In a bacterial model (Pseudomonas aeruginosa), the adsorp-
tion of PEG 15–20 kDa at 10% during 4 h and subsequent
washing induced a height deflection of the polymer/bacterial
surface of 1500 nm as measured by atomic force micro-
scopy.11
Thus, PEG molecules behave like ‘stealth molecules’
surrounded by a large cluster of structured water with a
near ‘ice-like’ structure. This layer at the cell membrane
surface contributes to the reduction of osmotic cell swelling
and permeability in numerous models.
PEG and glycocalyx
Receptors and signaling molecules at the cell surface are
associated with other membrane-associated proteoglycan,
glycosaminoglycans, glycoproteins, and glycolipids to con-
stitute the highly hydrated Gcx. The Gcx, by modulating its
density and thickness, is considered a physiological means of
regulating cell adhesion. It also contributes to the regulation
of cell volume.5 During ischemia and reperfusion, Gcx
integrity can be drastically altered.5,12 A decrease in Gcx
thickness exposes more signaling molecules, such as adhesion
molecules, according to their own size, and contributes to the
activation of coagulation. The Gcx is severely modified
45 nm
15 nm













Figure 2 | Immunological synapse and adsorbed PEG molecules of respective sizes. Left: the relative size of the signaling and adhesion
molecules involved in the formation of the immunological synapse between a lymphocyte T Cell and an antigen-presenting cell (APC).
Right: size at the identical scale of an adsorbed molecule of polyethylene glycol (PEG) of 20,000 Da MW.
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during IR, when a two-third reduction of its thickness can be
observed, likely reducing its protective effect against edema
and increasing the visibility of adhesion molecules and
other signalization molecules expressed at the membrane
surface. PEG molecules could protect or repair the Gcx,
restoring its regulatory function,13 and contribute to
immunocamouflage.14
PEG and oxidative stress
Polyethylene glycol has demonstrated membrane protective
effects in a variety of cells or organs against many different
types of insults. Moreover, PEGs are known to decrease ROS
elevation and lipid peroxidation in these injury models.
However, in vitro testing using cell-free systems demonstrated
that PEGs do not have the ability to scavenge the superoxide
anion DPPH (1,1-diphenyl-2-picrylhydrazyl) or the ability to
inhibit xanthine oxidase.12,13 It is thus likely that PEGs
inhibit or reduce oxidative stress mainly through the
preservation or restoration of membrane integrity and, thus,
could protect against ROS production during IR. Further-
more, the prevention of edema protects against mitochon-
drial swelling, which itself is a factor contributing to the
increase in ROS generation.
Pre-clinical evaluation of PEG
There is evidently a need for pre-clinical in vivo models,
which are probably more consistent for the evaluation of IRI
in transplantation. Many types of cultured cells undergo
apoptosis in the absence of specific survival factors, including
mechanical factors such as shear stresses.15 There is a big
difference between a flat layer of cells (two-dimensional) and
a complex three-dimensional tissue, questioning the rele-
vance of the study of IR and low-temperature effects in two-












































































































































































































































Figure 3 | PEG structure and hydratation layers. (a) A, PEG molecule backbone; B, cluster of structured water molecules bonded to
PEG molecule with long-lasting hydrogen bonds (dashed lines) (ice-like water); C, Area of dense water molecules with hydrogen bonds
of very short duration (liquid water). (b) Relation between the PEG structure and the size of proteins at the cell membrane surface.
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Previous evaluation by different laboratories has shown
that PEG is a viable strategy toward organ preservation when
added in a simplified crystalloid and extracellular solution.
To the best of our knowledge, the first published work
concerning the immunosuppressive effect of PEG-containing
solutions in humans is by Collins et al.16 They replaced
hydroxyethyl starch in a modified UW solution by PEG
20 kDa (50 g/L) to avoid osmotic swelling, and used it as a
preservation solution in cardiac transplantation in humans.
They report that, unexpectedly, the rate of acute rejection was
lower in the PEG group. They suggest a direct effect of PEG
solution on the immune process. The same immunoprotec-
tion was achieved when they used the PEG 20,000 solution
for the preservation of liver, small bowel, and pancreas.
Furthermore, the immunosuppressive effect of PEG was
dependent on the MW of the molecule. PEG 8000 was
ineffective, whereas when using PEG 20,000, the survival of
rats after small bowel transplantation was increased, and
moreover they did not show signs of acute rejection.17
More recently, the potential of PEG in organ preservation
has been demonstrated in kidney transplantation. In a model
of renal autotransplantation in the pig, the authors demon-
strated an absence of side effects in terms of recovery of organ
function and by showing a reduction in inflammation and
fibrosis development.6,18 In this model, kidney preservation
using PEG 20 kDa combined with extracellular solution
resulted in a faster renal recovery than UW solution. In this
model, PEG reduced tubular atrophy and fibrosis at 3
months after autotransplantation. Interestingly, additional
effects of PEG were a strong reduction of MHC class II
expression in epithelial tubule cells, a reduced number of
CD4þ T lymphocytes, limited infiltration of macrophages/
monocytes, and a lower progression of interstitial fibrosis in
the 8- to 12-week post-transplanted kidneys. These processes
are an important component of IRI, related to the
development of chronic injury, and make the graft more
susceptible to rejection.18 Considering the composition of the
solution, these effects can only be attributed to the presence
of PEG. Moreover, because this evidently efficient prototype
remains a simplified solution, there is room for other
additional molecules or biochemically active components,
which could be of interest to protect against cold ischemic
injury and the coupled effect of reperfusion and rewarming.
In addition, PEG was shown to induce an immunoprotection
of pancreatic islets transplants in an acute model of
rejection.19 This effect was observed using PEG dissolved
freely in the solution, but reactive species of PEG have also
been used for the protection of pancreatic islets. Activated
PEG allows covalent binding ensuring amine, carboxyl,
hydroxyl, thiol, or N-terminal PEGylation at the membrane
surface. For example, multiple PEGylation affected neither
islet viability nor functionality and, when allotransplanted
into diabetic recipients, these islets survived in three of the
seven recipients for more than 100 days without any
immunosuppressive treatment. In contrast, unmodified islets
were completely destroyed within 1 week.20 These data are
encouraging, but it should be mentioned that reactive PEG
cannot be used for cold storage, as there are issues with organ
perfusion at low pH. Nevertheless, these reactive PEGs are
well suited for preservation of islets, isolated large arteries, or
heart valves.
Clinical studies are in progress in different multicenter
studies. Preliminary results show that PEG is safely usable in
human kidney transplantation and provides a good quality of
preservation at least equivalent to UW.
CONCLUSION
New concepts regarding organ preservation and limitation of
IRI are emerging. The necessity to use low-Kþ solutions to
avoid vasoconstriction and high-molecular-weight molecules
to limit edema is obvious. Water-soluble polymers, such as
high-molecular-weight PEGs, can protect biological surfaces
in a nonspecific fashion. A PEG molecule combines two
protective actions: (i) it exerts an oncotic pressure that limits
the deleterious effects of edema and (ii) it is sufficiently
adsorbed at the cell membrane surfaces to stabilize
membrane lipids and ensure the immunocamouflage of
antigenic sites and may further enhance the immunoprotec-
tion of donor cells, tissues, and organs.
Immunocamouflage depends on the size of the exclusion
volume around PEG molecules. For nonactivated PEGs,
adsorption at the membrane surface is observed preferentially
for PEG 20,000. This MW ensures an exclusion layer of about
15–20 nm. The use of activated PEGs allows to fit the PEG size—
and thus the exclusion volume—to the size of the antigens of
interest. It is evident that the MW of PEG does matter, as PEG
8000 is not effective in ensuring immunoprotection and
biological data, illustrating that protection against IRI is obtai-
ned using mostly PEG 20,000. This effect can be undoubtedly
observed with higher MWs, as the limit is still unknown.
The main advantage of immunocamouflage is that it
directly modifies the inherent immunogenicity of the donor
tissue itself, using means that are strictly physicochemical in
nature and do not rely on the details of activation pathways,
leaving the immune system of the recipient fully competent.
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